Glenmark reports net profit at Rs 234 crore in Q2 Ruchika Sharma9 Nov 2020 9:00 AM ISTNew Delhi: Drug firm Glenmark Pharmaceuticals on Friday reported a consolidated net profit of Rs 233.99 crore for the second quarter ended...
Death During Glenmark Favipiravir-Umifenovir Trial: CDSCO seeks adverse event report Farhat Nasim15 Oct 2020 12:34 PM ISTNew Delhi: The Mumbai-based drugmaker, Glenmark Pharmaceuticals Ltd., has been directed by the apex drug regulator, Central Drugs Standard Control...
Glenmark launches pulmonary fibrosis drug NINDANIB in India Ruchika Sharma14 Oct 2020 1:00 PM ISTNintedanib is approved by the Indian drug regulator for the treatment of Idiopathic (unknown cause) Pulmonary Fibrosis (IPF).
CDSCO expert panel rejects Glenmark Favipiravir-Dexamethasone combination for COVID treatment Farhat Nasim11 Oct 2020 11:30 AM ISTNew Delhi: In a major setback to Glenmark, the Subject Expert Committee of the apex the drug regulator, Central Drugs Standard Control Organisation...
Combining Umifenovir, Favipiravir for mild COVID treatment did not show benefit: Glenmark MD Bureau9 Oct 2020 9:05 PM ISTThe addition of Umifenovir did not demonstrate any additional benefit over Favipiravir alone in moderate Covid-19 patients, Glenmark said.
Five months after COVID crisis, drug sales report growth of 4.5 percent at Rs 13170 crore: AIOCD-AWACS Report Farhat Nasim7 Oct 2020 5:41 PM ISTNew Delhi: The Indian Pharma Market for the first time has come back very strongly after 5 months of the COVID crisis and registered a growth of 4.5%...
Glenmark gets USFDA approval for Dimethyl Fumarate Delayed-Release Capsules Ruchika Sharma7 Oct 2020 3:13 PM ISTMumbai: Glenmark Pharmaceuticals Inc., USA today announced that the company has been granted final approval by the United States Food & Drug...
Indian Pharma sees decline in August 2020, anti-infectives, respiratory segments see major slumps: AIOCD-AWACS report Farhat Nasim12 Sept 2020 1:08 PM ISTNew Delhi: Amid the ongoing COVID-19 crisis, the month of August remained unfavorable for the Indian pharmaceutical market as data from market...
NPPA fixes retail price of Glenmark Vildagliptin, Metformin combo drug at Rs 6.17 per tablet Farhat Nasim1 Sept 2020 2:26 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has recently fixed the price of popular combination formulation, Vildagliptin +...
Dipankar Bhattacharjee appointed as new Independent Non-Executive Director of Glenmark Ruchika Sharma18 Aug 2020 12:14 PM ISTMumbai: Glenmark Pharmaceuticals has announced the appointment of Mr. Dipankar Bhattacharjee as Independent Non-Executive Director on the...
Glenmark net profit leaps over two fold to Rs 254 crore in Q1 Ruchika Sharma17 Aug 2020 10:15 AM ISTNew Delhi: Glenmark Pharmaceuticals on Friday posted an over two-fold increase in consolidated net profit at Rs 254.04 crore for the quarter...
Govt incentives for domestic API to cut supply risk for Indian drug makers: Fitch Ruchika Sharma11 Aug 2020 12:00 PM ISTThe production-linked incentive scheme -- which accounts for Rs 90 crore of planned outlay -- offers an incentive of up to 20 per cent of sales for...
